BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17172773)

  • 1. Pilot cluster-randomised trial of adjunctive motivational interviewing to reduce crack cocaine use in clients on methadone maintenance.
    Mitcheson L; McCambridge J; Byrne S
    Eur Addict Res; 2007; 13(1):6-10. PubMed ID: 17172773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs.
    Silverman K; Robles E; Mudric T; Bigelow GE; Stitzer ML
    J Consult Clin Psychol; 2004 Oct; 72(5):839-54. PubMed ID: 15482042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study.
    Sofuoglu M; Poling J; Gonzalez G; Gonsai K; Oliveto A; Kosten TR
    Exp Clin Psychopharmacol; 2007 Oct; 15(5):453-60. PubMed ID: 17924779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single- versus dual-drug target: effects in a brief abstinence incentive procedure.
    Correia CJ; Dallery J; Katz EC; Silverman K; Bigelow G; Stitzer ML
    Exp Clin Psychopharmacol; 2003 Nov; 11(4):302-8. PubMed ID: 14599264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to treatment-related and support services in methadone treatment programs.
    Berkman ND; Wechsberg WM
    J Subst Abuse Treat; 2007 Jan; 32(1):97-104. PubMed ID: 17175403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico.
    Heimer R; Catania H; Newman RG; Zambrano J; Brunet A; Ortiz AM
    Drug Alcohol Depend; 2006 Jun; 83(2):122-9. PubMed ID: 16332415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diversified prescription of narcotics to heroin addicts. Basis, design, research plan].
    Uchtenhagen A
    Schweiz Rundsch Med Prax; 1994 Aug; 83(34):931-6. PubMed ID: 7939045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between heroin and heroin-cocaine polyabusers: a psychopathological study.
    Bandettini Di Poggio A; Fornai F; Paparelli A; Pacini M; Perugi G; Maremmani I
    Ann N Y Acad Sci; 2006 Aug; 1074():438-45. PubMed ID: 17105942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic.
    Petry NM; Martin B; Simcic F
    J Consult Clin Psychol; 2005 Apr; 73(2):354-9. PubMed ID: 15796645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting cocaine group treatment outcome in cocaine-abusing methadone patients.
    Tzilos GK; Rhodes GL; Ledgerwood DM; Greenwald MK
    Exp Clin Psychopharmacol; 2009 Oct; 17(5):320-5. PubMed ID: 19803631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What do we get for our money? Cost-effectiveness of adding contingency management.
    Sindelar J; Elbel B; Petry NM
    Addiction; 2007 Feb; 102(2):309-16. PubMed ID: 17222286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine abstinence during methadone maintenance: effects of repeated brief exposure to voucher-based reinforcement.
    Sigmon SC; Correia CJ; Stitzer ML
    Exp Clin Psychopharmacol; 2004 Nov; 12(4):269-75. PubMed ID: 15571444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motivational factors in cocaine pharmacotherapy trials with methadone-maintained patients: problems and paradoxes.
    Margolin A; Avants SK; Rounsaville B; Kosten TR; Schottenfeld RS
    J Psychoactive Drugs; 1997; 29(2):205-12. PubMed ID: 9250948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN).
    Fischer B; Cruz MF; Patra J; Rehm J
    J Subst Abuse Treat; 2008 Apr; 34(3):340-6. PubMed ID: 17614236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients.
    Wittchen HU; Apelt SM; Soyka M; Gastpar M; Backmund M; Gölz J; Kraus MR; Tretter F; Schäfer M; Siegert J; Scherbaum N; Rehm J; Bühringer G
    Drug Alcohol Depend; 2008 Jun; 95(3):245-57. PubMed ID: 18337025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motivational interviewing and cognitive behaviour therapy in the treatment of adolescent overweight and obesity: study design and methodology.
    Brennan L; Walkley J; Fraser SF; Greenway K; Wilks R
    Contemp Clin Trials; 2008 May; 29(3):359-75. PubMed ID: 17950046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).
    Roux P; Lions C; Vilotitch A; Michel L; Mora M; Maradan G; Marcellin F; Spire B; Morel A; Carrieri PM;
    Harm Reduct J; 2016 Apr; 13():12. PubMed ID: 27048152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motivational interviewing with hazardous drinkers.
    Beckham N
    J Am Acad Nurse Pract; 2007 Feb; 19(2):103-10. PubMed ID: 17300536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.